Educational objectives
The Master intends to provide knowledge and skills, not only of a technical nature, but also of an economic, legal-regulatory and managerial nature in the pharmaceutical and device sector.
Participants will therefore acquire the fundamental knowledge to master the entire process (experimental, normative and regulatory) of a new drug for human health, essential knowledge to be protagonists in the professions of the sector.
Recipients and access requirements
The Master is aimed at recent graduates and professionals in possession of a degree under the old system, or a specialist or a master's degree. Those who do not possess the required qualification will be able to attend the Master as auditors.
Didactic structure and thematic areas
The Master is structured in 6 thematic areas:
- The context: ethics, competitiveness, pre-clinical path
- Management and conduct of a study
- Regulatory, legal and insurance aspects
- Role of technological and social health innovation
- Trials of medical devices: reference contexts
- Authorization procedures and market access
The BLENDED and PART-TIME FORMULA makes the Master compatible and contextual with professional commitments and responsibilities. The teaching structure will be divided into 70% of the lessons in presence and 30% of the lessons in live streaming.
Attendance fee
The Master requires a participation fee of € 5.000,00 with the possibility of payment in installments.
Reduced rates are reserved for undergraduates, graduates, UCBM Academy Ambassador and staff of the Campus Bio-Medico University Hospital Foundation.
All payments, including the one relating to the admission application, must be made to the bank current account held in the name of:
Università Campus Bio-Medico di Roma
IBAN: IT32Q0306905020100000077054
Specify the reason for each payment (Name and Surname - Master in Clinical Research).
For the most deserving candidates for the Master, Farmindustria offers 2 full-coverage scholarships. These scholarships will be awarded to candidates admitted to the Master with the highest score, to young graduates or to candidates already in the biomedical field who are not employees of pharmaceutical companies
Method of admission
The application for admission to the Master must be submitted by 10 November 2022 using the accessible online procedure clicking here which involves:
- personal data
- curriculum vitae
- Ofchiarasubstitutive certification
The motivational interviews will take place atUniversità Campus Bio-Medico di Roma on December 2, 2022.
Having read the admission, enrollment in the Master must be completed by 12 December 2022.
Title awarded
II level University Master in Clinical Research, open innovation and market access in the digital age with the award of 60 university credits (CFU).
Those enrolled as auditors will not obtain the academic qualification, but at the end of the course they will be issued with a certificate of attendance at the Master's.
